After a study that lasted over five years, Chinese researchers are now close to understanding the genes behind the development of aggressive breast cancer
Women all over the world must sooner or later clash with the possibility of developing breast cancer and this is one of the most frightening diseases. In China, after a five-year study, Chinese researchers are now close to understanding triple negative breast cancer, an aggressive type of the disease.
Leading the study was Professor Shao Zhimin of the Fudan University Shanghai Cancer Center and his team, who found that triple negative breast cancer is not a single disease, but several genetic mutations in different subtypes.
The study involved over 460 samples and built the cancer gene map
The study involved over 460 samples and built the largest triple negative breast cancer gene map in the world using gene sequencing technology. Thanks to the data collected, the research team will begin clinical trials to develop targeted drugsas soon as possible.
If the scientific community is able to identify the types of gene mutation through clinical trials, it will be easier to identify potential patients early and receive more precise treatment, Shao said. The proportion of these mutations in Chinese patients was significantly higher than in the United States.